Consistently, YPB and OPB peptides could increase the cleavage of PARP and caspase 3 in these breast cancer cell lines when evaluated by Western blot analysis (Figure 3E–G), validating their pro-apoptotic activity in these cells. Here, CASP3 is linked to breast cancer.